J. Breul

445 total citations
14 papers, 318 citations indexed

About

J. Breul is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, J. Breul has authored 14 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in J. Breul's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Hormonal and reproductive studies (2 papers). J. Breul is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Hormonal and reproductive studies (2 papers). J. Breul collaborates with scholars based in Germany. J. Breul's co-authors include R. Härtung, Christian Höfer, Markus Schwaiger, Kai Tobias Block, C. Laubenbacher, Roger Paul, Norbert Avril, J. Schaff, R. Paul and D. J. Schendel and has published in prestigious journals such as European Urology, Drug Safety and The Journal of Gene Medicine.

In The Last Decade

J. Breul

13 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Breul Germany 5 243 132 57 46 35 14 318
T Kotake Japan 12 175 0.7× 36 0.3× 127 2.2× 45 1.0× 111 3.2× 45 406
Sameh Hijazi Germany 6 309 1.3× 224 1.7× 28 0.5× 25 0.5× 23 0.7× 16 364
J.D. Forman United States 9 274 1.1× 33 0.3× 34 0.6× 74 1.6× 52 1.5× 23 358
Weiqing Han China 11 137 0.6× 70 0.5× 177 3.1× 55 1.2× 75 2.1× 23 382
Muhammad Junaid Niaz United States 13 261 1.1× 244 1.8× 35 0.6× 35 0.8× 51 1.5× 35 371
Marguerite du Plessis United States 7 199 0.8× 39 0.3× 80 1.4× 65 1.4× 46 1.3× 22 290
Eduardo I. Canto United States 10 336 1.4× 41 0.3× 84 1.5× 39 0.8× 54 1.5× 17 415
Joy S. Kim United States 12 332 1.4× 43 0.3× 54 0.9× 126 2.7× 123 3.5× 15 472
Liangren Liu China 10 177 0.7× 20 0.2× 73 1.3× 70 1.5× 109 3.1× 15 337
Maarten J. van der Doelen Netherlands 9 239 1.0× 172 1.3× 16 0.3× 46 1.0× 31 0.9× 20 278

Countries citing papers authored by J. Breul

Since Specialization
Citations

This map shows the geographic impact of J. Breul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Breul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Breul more than expected).

Fields of papers citing papers by J. Breul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Breul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Breul. The network helps show where J. Breul may publish in the future.

Co-authorship network of co-authors of J. Breul

This figure shows the co-authorship network connecting the top 25 collaborators of J. Breul. A scholar is included among the top collaborators of J. Breul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Breul. J. Breul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Brill, T., Hubert Kübler, Falko Fend, et al.. (2007). Allogeneic retrovirally transduced, IL‐2‐ and IFN‐γ‐secreting cancer cell vaccine in patients with hormone refractory prostate cancer—a phase I clinical trial. The Journal of Gene Medicine. 9(7). 547–560. 19 indexed citations
2.
Härtung, R., et al.. (2001). Diagnosis and Monitoring of Urological Tumors Using Positron Emission Tomography. European Urology. 40(5). 481–487. 38 indexed citations
3.
Brill, T., et al.. (2001). Gentherapie des Prostatakarzinoms. Der Internist. 42(10). 1328–1345. 1 indexed citations
4.
Randenborgh, H. Van, et al.. (2001). Neoadjuvante Hormontherapie des lokalisierten Prostatakarzinoms vor kurativer radikaler Prostatektomie - Vorteil oder Nachteil?. Aktuelle Urologie. 32(4). 165–172. 1 indexed citations
5.
Paul, Roger & J. Breul. (2000). Antiandrogen Withdrawal Syndrome Associated with Prostate Cancer Therapies. Drug Safety. 23(5). 381–390. 38 indexed citations
6.
Höfer, Christian, C. Laubenbacher, Kai Tobias Block, et al.. (1999). Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy. European Urology. 36(1). 31–35. 193 indexed citations
7.
Breul, J. & Ryan Paul. (1998). Antiandrogen with drawal syndrome. Der Urologe. 37(2). 156–158. 2 indexed citations
8.
Breul, J. & R. Paul. (1998). Palliative Therapie des Prostatakarzinoms. Der Urologe B. 38(3). 262–265.
9.
Paul, R., et al.. (1997). Nebenmilz des Samenstrangs. Der Urologe. 36(3). 262–264. 1 indexed citations
10.
Breul, J., et al.. (1997). Extraprostatic production of prostate specific antigen is under hormonal control.. PubMed. 157(1). 212–3. 20 indexed citations
11.
Breul, J., et al.. (1996). Das “Antiandrogen-Entzugssyndrom”. Aktuelle Urologie. 27(5). 267–270. 1 indexed citations
12.
Breul, J., et al.. (1996). Prätherapeutisches Staging beim Prostatakarzinom. Der Onkologe. 2(3). 214–217. 1 indexed citations
14.
Bürger, G., et al.. (1994). High resolution image-cytometric differentiation of hormone sensitive and hormone insensitive prostatic carcinomas.. PubMed. 7(2). 139–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026